Shanghai, China - May 27, 2020
Based on the analysis of the current situation of investment and financing in the medical industry, CHC medical consulting and CITIC Securities Co., Ltd, online released the "honor list of investment and financing in China's major medical and health industry in 2019". Viva biotech was selected in the list and won the Best Medical Service Listed Company.
Viva Biotech operates a leading structure-based, integrated drug discovery platform, providing structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their preclinical stage innovative drug development. We actively combine the conventional cash-for-service (CFS) and unique equity-for-service (EFS) approaches to realize the combination of short-term drug-discovery services business (steady cash inflow) and long-term incubation investment (high-yield returns).
Copyright © Viva Biotech All Rights Reserved. 沪ICP备19036061号
- About Us
-
CRO Services
BackCRO ServicesDiscovery Biology Services
- CDMO Services
- EFS Business
- News
- Careers
- Investor Relations
- Contact Us